Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 999,500 | 2,503,300 | 1,237,500 | 1,651,400 | 788,500 |
| Marketable Securities | 1,618,800 | 3,411,600 | 3,318,400 | 322,300 | 995,200 |
| Receivables | 2,800,600 | 3,192,300 | 3,012,300 | 3,086,300 | 2,731,200 |
| Inventories | 1,199,900 | 1,133,100 | 1,083,100 | 1,004,500 | 943,200 |
| Other current assets | 0 | 0 | 0 | 0 | 45,700 |
| TOTAL | $7,474,100 | $11,126,700 | $9,593,600 | $8,572,800 | $6,289,300 |
| Non-Current Assets | |||||
| PPE Net | 1,915,400 | 1,926,500 | 1,857,000 | 1,821,000 | 1,781,100 |
| Investments And Advances | 430,700 | 408,000 | 367,900 | 335,200 | 1,979,500 |
| Intangibles | 77,495,400 | 80,138,900 | 81,592,300 | 83,572,200 | 85,601,200 |
| Other Non-Current Assets | 1,110,600 | 1,099,010 | 998,100 | 1,179,510 | 2,385,210 |
| TOTAL | $80,952,100 | $83,572,410 | $84,815,300 | $86,907,910 | $91,747,010 |
| Total Assets | $88,426,200 | $94,699,100 | $94,408,900 | $95,480,700 | $98,036,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,950,700 | 4,532,500 | 3,739,200 | 3,094,200 | 3,971,800 |
| Accounts payable and accrued liabilities | 5,289,500 | 6,348,700 | 5,692,200 | 4,995,300 | 4,634,400 |
| TOTAL | $7,433,400 | $11,070,700 | $9,638,700 | $8,303,700 | $8,849,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,599,000 | 18,116,500 | 18,786,000 | 19,609,300 | 19,554,100 |
| Other Non-Current Liabilities | 2,915,100 | 2,951,900 | 2,965,500 | 2,899,100 | 2,837,100 |
| TOTAL | $22,971,300 | $25,432,000 | $26,272,000 | $27,480,900 | $27,627,500 |
| Total Liabilities | $30,404,700 | $36,502,700 | $35,910,700 | $35,784,600 | $36,476,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 329,806 | 329,002 | 328,277 | 328,033 | 327,802 |
| Retained earnings | 882,500 | 991,500 | 1,551,700 | 2,581,100 | 4,582,800 |
| Other shareholders' equity | 1,102,800 | 1,230,000 | 1,064,100 | 1,303,100 | 1,234,000 |
| TOTAL | $58,021,500 | $58,196,400 | $58,498,200 | $59,696,100 | $61,559,600 |
| Total Liabilities And Equity | $88,426,200 | $94,699,100 | $94,408,900 | $95,480,700 | $98,036,300 |